

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of granulocyte differentiation (GO:0030854) | 4.77629364 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.59755388 |
| 3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.47359130 |
| 4 | activated T cell proliferation (GO:0050798) | 4.45199428 |
| 5 | negative T cell selection (GO:0043383) | 4.30668517 |
| 6 | positive thymic T cell selection (GO:0045059) | 4.26188020 |
| 7 | negative thymic T cell selection (GO:0045060) | 4.08187190 |
| 8 | positive T cell selection (GO:0043368) | 4.07435009 |
| 9 | response to interleukin-15 (GO:0070672) | 3.98632280 |
| 10 | cellular response to interleukin-15 (GO:0071350) | 3.91425182 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.85799313 |
| 12 | thymic T cell selection (GO:0045061) | 3.67748759 |
| 13 | DNA deamination (GO:0045006) | 3.66066339 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.55275067 |
| 15 | S-adenosylmethionine metabolic process (GO:0046500) | 3.52831869 |
| 16 | mast cell activation involved in immune response (GO:0002279) | 3.44204894 |
| 17 | mast cell degranulation (GO:0043303) | 3.44204894 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39145714 |
| 19 | disruption of cells of other organism (GO:0044364) | 3.36261296 |
| 20 | killing of cells of other organism (GO:0031640) | 3.36261296 |
| 21 | positive regulation of B cell differentiation (GO:0045579) | 3.32573081 |
| 22 | T cell selection (GO:0045058) | 3.31319413 |
| 23 | sulfation (GO:0051923) | 3.27445955 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.20580517 |
| 25 | negative regulation of cell killing (GO:0031342) | 3.20580517 |
| 26 | regulation of granulocyte differentiation (GO:0030852) | 3.20157375 |
| 27 | Peyers patch development (GO:0048541) | 3.18303255 |
| 28 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.18303255 |
| 29 | oxygen transport (GO:0015671) | 3.17395528 |
| 30 | regulation of B cell differentiation (GO:0045577) | 3.15898398 |
| 31 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.10609742 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09873275 |
| 33 | regulation of activation of Janus kinase activity (GO:0010533) | 3.07058358 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 3.03678583 |
| 35 | cytidine catabolic process (GO:0006216) | 3.02943985 |
| 36 | cytidine deamination (GO:0009972) | 3.02943985 |
| 37 | cytidine metabolic process (GO:0046087) | 3.02943985 |
| 38 | imidazole-containing compound metabolic process (GO:0052803) | 3.02341191 |
| 39 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.99145895 |
| 40 | mast cell activation (GO:0045576) | 2.87313709 |
| 41 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.85207546 |
| 42 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.85137676 |
| 43 | histone H3-K9 modification (GO:0061647) | 2.83707275 |
| 44 | mannose metabolic process (GO:0006013) | 2.83540486 |
| 45 | negative regulation of T cell mediated immunity (GO:0002710) | 2.82066743 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 2.80235385 |
| 47 | B cell receptor signaling pathway (GO:0050853) | 2.77921734 |
| 48 | fucose catabolic process (GO:0019317) | 2.77312293 |
| 49 | L-fucose metabolic process (GO:0042354) | 2.77312293 |
| 50 | L-fucose catabolic process (GO:0042355) | 2.77312293 |
| 51 | interferon-gamma production (GO:0032609) | 2.75682791 |
| 52 | exogenous drug catabolic process (GO:0042738) | 2.75269112 |
| 53 | behavioral response to nicotine (GO:0035095) | 2.75118985 |
| 54 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.74782244 |
| 55 | histone H3-K9 methylation (GO:0051567) | 2.74416149 |
| 56 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.73059975 |
| 57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72958403 |
| 58 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.70127544 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 2.68189293 |
| 60 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.68103009 |
| 61 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.68103009 |
| 62 | autophagic vacuole fusion (GO:0000046) | 2.67223750 |
| 63 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.66679279 |
| 64 | regulation of natural killer cell differentiation (GO:0032823) | 2.65396117 |
| 65 | positive regulation of defense response to virus by host (GO:0002230) | 2.63137593 |
| 66 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.61220987 |
| 67 | defense response to fungus (GO:0050832) | 2.60630093 |
| 68 | drug catabolic process (GO:0042737) | 2.59729735 |
| 69 | positive regulation of protein homodimerization activity (GO:0090073) | 2.58785576 |
| 70 | short-chain fatty acid metabolic process (GO:0046459) | 2.57334905 |
| 71 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.56205705 |
| 72 | adaptation of signaling pathway (GO:0023058) | 2.54217946 |
| 73 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.54041091 |
| 74 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.53279737 |
| 75 | negative regulation of adaptive immune response (GO:0002820) | 2.52785234 |
| 76 | cellular extravasation (GO:0045123) | 2.52779697 |
| 77 | iron-sulfur cluster assembly (GO:0016226) | 2.52179725 |
| 78 | metallo-sulfur cluster assembly (GO:0031163) | 2.52179725 |
| 79 | T cell migration (GO:0072678) | 2.51958861 |
| 80 | potassium ion export (GO:0071435) | 2.50760885 |
| 81 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.50240024 |
| 82 | negative regulation of telomere maintenance (GO:0032205) | 2.49456146 |
| 83 | gas transport (GO:0015669) | 2.47391175 |
| 84 | detection of bacterium (GO:0016045) | 2.46522744 |
| 85 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.45652147 |
| 86 | regulation of memory T cell differentiation (GO:0043380) | 2.45626761 |
| 87 | positive regulation by host of viral transcription (GO:0043923) | 2.44228749 |
| 88 | omega-hydroxylase P450 pathway (GO:0097267) | 2.43851062 |
| 89 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.43298509 |
| 90 | rRNA catabolic process (GO:0016075) | 2.43108663 |
| 91 | positive regulation of T cell cytokine production (GO:0002726) | 2.41953914 |
| 92 | histone H2A acetylation (GO:0043968) | 2.38624235 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.38562913 |
| 94 | regulation of T cell cytokine production (GO:0002724) | 2.37672101 |
| 95 | indole-containing compound catabolic process (GO:0042436) | 2.37221616 |
| 96 | indolalkylamine catabolic process (GO:0046218) | 2.37221616 |
| 97 | tryptophan catabolic process (GO:0006569) | 2.37221616 |
| 98 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.35416751 |
| 99 | regulation of lipoprotein particle clearance (GO:0010984) | 2.35155379 |
| 100 | actin nucleation (GO:0045010) | 2.34395300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.41691156 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.71617231 |
| 3 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.69838443 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.62584185 |
| 5 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.47742521 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.43169373 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.42777463 |
| 8 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.27293912 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.25353392 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.16927178 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10201598 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.10137252 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06119269 |
| 14 | MAF_26560356_Chip-Seq_TH2_Human | 2.05493983 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.01632773 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 1.97310345 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96929610 |
| 18 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.94536081 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.92937544 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.92864904 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.84884428 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.81202476 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79234265 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.75597226 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75468919 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.73816121 |
| 27 | P68_20966046_ChIP-Seq_HELA_Human | 1.73710335 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.72923467 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72515110 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.70928314 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66627138 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.64527765 |
| 33 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.62637922 |
| 34 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.62226003 |
| 35 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.62093552 |
| 36 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.61704089 |
| 37 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.58350804 |
| 38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57152020 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55491160 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.53302265 |
| 41 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.51655732 |
| 42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50362308 |
| 43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49336281 |
| 44 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.48779886 |
| 45 | ERA_21632823_ChIP-Seq_H3396_Human | 1.48553506 |
| 46 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.45160663 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43727458 |
| 48 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.42947444 |
| 49 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.38523248 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36916724 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36364899 |
| 52 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.31908275 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30440630 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30291161 |
| 55 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.27609658 |
| 56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27496952 |
| 57 | P300_27268052_Chip-Seq_Bcells_Human | 1.26399888 |
| 58 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.25573076 |
| 59 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.24439821 |
| 60 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24185140 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23574513 |
| 62 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23440662 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23017461 |
| 64 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.21840094 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21795889 |
| 66 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.21676422 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21387875 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21016187 |
| 69 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20184028 |
| 70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19839589 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19715862 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19714013 |
| 73 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.19197798 |
| 74 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.18819128 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.18115629 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17043729 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16951127 |
| 78 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16903094 |
| 79 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.16016280 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15542376 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14707456 |
| 82 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13845321 |
| 83 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13358429 |
| 84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.11830526 |
| 85 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.11309268 |
| 86 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.10808803 |
| 87 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09960396 |
| 88 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09883658 |
| 89 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.09595254 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09307101 |
| 91 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08870226 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08843390 |
| 93 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.07390164 |
| 94 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07127296 |
| 95 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.06263834 |
| 96 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.05645271 |
| 97 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.05184591 |
| 98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03301756 |
| 99 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03188453 |
| 100 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02800787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 3.86000245 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.28644204 |
| 3 | MP0004147_increased_porphyrin_level | 3.12434690 |
| 4 | MP0005671_abnormal_response_to | 2.77729439 |
| 5 | MP0005360_urolithiasis | 2.41726059 |
| 6 | MP0008995_early_reproductive_senescence | 2.27594664 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 2.13320820 |
| 8 | MP0001800_abnormal_humoral_immune | 2.04598936 |
| 9 | MP0001986_abnormal_taste_sensitivity | 1.77457551 |
| 10 | MP0000703_abnormal_thymus_morphology | 1.75705110 |
| 11 | MP0009278_abnormal_bone_marrow | 1.75143288 |
| 12 | MP0002398_abnormal_bone_marrow | 1.74177332 |
| 13 | MP0000685_abnormal_immune_system | 1.71756672 |
| 14 | MP0002653_abnormal_ependyma_morphology | 1.68259540 |
| 15 | MP0001835_abnormal_antigen_presentation | 1.68020760 |
| 16 | MP0003195_calcinosis | 1.65522411 |
| 17 | MP0002249_abnormal_larynx_morphology | 1.64979129 |
| 18 | MP0003436_decreased_susceptibility_to | 1.63868371 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.63650888 |
| 20 | MP0002723_abnormal_immune_serum | 1.63383559 |
| 21 | MP0001873_stomach_inflammation | 1.63042064 |
| 22 | MP0001819_abnormal_immune_cell | 1.62267945 |
| 23 | MP0005451_abnormal_body_composition | 1.59529139 |
| 24 | MP0002722_abnormal_immune_system | 1.57623404 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.57117068 |
| 26 | MP0005025_abnormal_response_to | 1.56905856 |
| 27 | MP0001764_abnormal_homeostasis | 1.56599140 |
| 28 | MP0000689_abnormal_spleen_morphology | 1.55368392 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.53022140 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.52489537 |
| 31 | MP0002132_abnormal_respiratory_system | 1.50750997 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.50166855 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.50166855 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49618915 |
| 35 | MP0009785_altered_susceptibility_to | 1.47506887 |
| 36 | MP0000716_abnormal_immune_system | 1.45647986 |
| 37 | MP0001790_abnormal_immune_system | 1.42394852 |
| 38 | MP0005387_immune_system_phenotype | 1.42394852 |
| 39 | MP0002405_respiratory_system_inflammati | 1.40334239 |
| 40 | MP0001529_abnormal_vocalization | 1.39225851 |
| 41 | MP0006035_abnormal_mitochondrial_morpho | 1.38630749 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.33715236 |
| 43 | MP0001270_distended_abdomen | 1.32384157 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.29570731 |
| 45 | MP0004142_abnormal_muscle_tone | 1.27908620 |
| 46 | MP0002822_catalepsy | 1.27562844 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.27426240 |
| 48 | MP0002429_abnormal_blood_cell | 1.21749220 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.20461006 |
| 50 | MP0001968_abnormal_touch/_nociception | 1.18663681 |
| 51 | MP0010329_abnormal_lipoprotein_level | 1.16364230 |
| 52 | MP0003786_premature_aging | 1.15331424 |
| 53 | MP0005365_abnormal_bile_salt | 1.15295235 |
| 54 | MP0005377_hearing/vestibular/ear_phenot | 1.15263907 |
| 55 | MP0003878_abnormal_ear_physiology | 1.15263907 |
| 56 | MP0008872_abnormal_physiological_respon | 1.14899225 |
| 57 | MP0003866_abnormal_defecation | 1.13134395 |
| 58 | MP0004381_abnormal_hair_follicle | 1.10981456 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.10104424 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.09037032 |
| 61 | MP0002419_abnormal_innate_immunity | 1.08830570 |
| 62 | MP0003252_abnormal_bile_duct | 1.05192980 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.04819605 |
| 64 | MP0002396_abnormal_hematopoietic_system | 0.94050558 |
| 65 | MP0001984_abnormal_olfaction | 0.93154980 |
| 66 | MP0002933_joint_inflammation | 0.92795228 |
| 67 | MP0002102_abnormal_ear_morphology | 0.91698822 |
| 68 | MP0005083_abnormal_biliary_tract | 0.91232692 |
| 69 | MP0001845_abnormal_inflammatory_respons | 0.86213143 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 0.85826457 |
| 71 | MP0008058_abnormal_DNA_repair | 0.85086390 |
| 72 | MP0005551_abnormal_eye_electrophysiolog | 0.83657064 |
| 73 | MP0001501_abnormal_sleep_pattern | 0.83156398 |
| 74 | MP0003303_peritoneal_inflammation | 0.82193284 |
| 75 | MP0010155_abnormal_intestine_physiology | 0.76937895 |
| 76 | MP0008961_abnormal_basal_metabolism | 0.75615102 |
| 77 | MP0002009_preneoplasia | 0.75497629 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 0.75383113 |
| 79 | MP0000609_abnormal_liver_physiology | 0.73782893 |
| 80 | MP0008469_abnormal_protein_level | 0.73305236 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 0.73245130 |
| 82 | MP0001486_abnormal_startle_reflex | 0.72735221 |
| 83 | MP0005646_abnormal_pituitary_gland | 0.72039766 |
| 84 | MP0003646_muscle_fatigue | 0.71212630 |
| 85 | MP0003698_abnormal_male_reproductive | 0.70829834 |
| 86 | MP0006072_abnormal_retinal_apoptosis | 0.70369180 |
| 87 | MP0002928_abnormal_bile_duct | 0.70246809 |
| 88 | MP0005253_abnormal_eye_physiology | 0.69303000 |
| 89 | MP0002277_abnormal_respiratory_mucosa | 0.69032503 |
| 90 | MP0005448_abnormal_energy_balance | 0.68393504 |
| 91 | MP0004130_abnormal_muscle_cell | 0.67974400 |
| 92 | MP0009764_decreased_sensitivity_to | 0.67965760 |
| 93 | MP0003724_increased_susceptibility_to | 0.67416049 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.67265544 |
| 95 | MP0006292_abnormal_olfactory_placode | 0.67097307 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.64943480 |
| 97 | MP0004742_abnormal_vestibular_system | 0.64143009 |
| 98 | MP0005171_absent_coat_pigmentation | 0.63651059 |
| 99 | MP0001663_abnormal_digestive_system | 0.63233376 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 0.62498422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.41303509 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 3.69478781 |
| 3 | Panhypogammaglobulinemia (HP:0003139) | 3.62597915 |
| 4 | Optic neuritis (HP:0100653) | 3.46369236 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 3.46369236 |
| 6 | Myositis (HP:0100614) | 3.40624387 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 3.33080696 |
| 8 | Pustule (HP:0200039) | 3.25746874 |
| 9 | Poikilocytosis (HP:0004447) | 3.07248338 |
| 10 | Hypochromic anemia (HP:0001931) | 2.99258204 |
| 11 | Orchitis (HP:0100796) | 2.96118982 |
| 12 | Abnormality of DNA repair (HP:0003254) | 2.79633839 |
| 13 | Recurrent fungal infections (HP:0002841) | 2.76397117 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.71084838 |
| 15 | Granulocytopenia (HP:0001913) | 2.70940903 |
| 16 | Abnormality of eosinophils (HP:0001879) | 2.67307001 |
| 17 | IgG deficiency (HP:0004315) | 2.65517468 |
| 18 | Stomatitis (HP:0010280) | 2.64618709 |
| 19 | Pancreatic cysts (HP:0001737) | 2.64390008 |
| 20 | Reticulocytosis (HP:0001923) | 2.63217200 |
| 21 | Congenital stationary night blindness (HP:0007642) | 2.61710000 |
| 22 | Cerebral palsy (HP:0100021) | 2.51551608 |
| 23 | Meningitis (HP:0001287) | 2.47777938 |
| 24 | Keratoconjunctivitis (HP:0001096) | 2.39663753 |
| 25 | Abnormal number of erythroid precursors (HP:0012131) | 2.36720313 |
| 26 | Abnormal biliary tract physiology (HP:0012439) | 2.35819339 |
| 27 | Bile duct proliferation (HP:0001408) | 2.35819339 |
| 28 | Retinal dysplasia (HP:0007973) | 2.35797787 |
| 29 | Type II lissencephaly (HP:0007260) | 2.34711772 |
| 30 | T lymphocytopenia (HP:0005403) | 2.33367327 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 2.33004361 |
| 32 | Eosinophilia (HP:0001880) | 2.30954116 |
| 33 | Obstructive lung disease (HP:0006536) | 2.28472572 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28472572 |
| 35 | Thyroiditis (HP:0100646) | 2.25882096 |
| 36 | Keratitis (HP:0000491) | 2.24265126 |
| 37 | Encephalitis (HP:0002383) | 2.23939018 |
| 38 | Abnormality of T cells (HP:0002843) | 2.23799103 |
| 39 | Large for gestational age (HP:0001520) | 2.22624323 |
| 40 | Combined immunodeficiency (HP:0005387) | 2.20325605 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17693970 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17693970 |
| 43 | Agammaglobulinemia (HP:0004432) | 2.17101907 |
| 44 | Progressive cerebellar ataxia (HP:0002073) | 2.15618098 |
| 45 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.13941536 |
| 46 | Pancreatic fibrosis (HP:0100732) | 2.12143807 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.10958373 |
| 48 | Methylmalonic acidemia (HP:0002912) | 2.10687249 |
| 49 | Hemoptysis (HP:0002105) | 2.08997780 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.08991644 |
| 51 | Microcytic anemia (HP:0001935) | 2.06734536 |
| 52 | Abnormality of reticulocytes (HP:0004312) | 2.03745448 |
| 53 | Gastrointestinal infarctions (HP:0005244) | 2.02446343 |
| 54 | Ketosis (HP:0001946) | 2.02264675 |
| 55 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.00402607 |
| 56 | Pendular nystagmus (HP:0012043) | 1.99400732 |
| 57 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.98870650 |
| 58 | Abnormality of the pleura (HP:0002103) | 1.97909856 |
| 59 | True hermaphroditism (HP:0010459) | 1.97526313 |
| 60 | Pulmonary infiltrates (HP:0002113) | 1.96860271 |
| 61 | Pulmonary embolism (HP:0002204) | 1.95589079 |
| 62 | Methylmalonic aciduria (HP:0012120) | 1.95516733 |
| 63 | Nephronophthisis (HP:0000090) | 1.94713625 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94403782 |
| 65 | Cystic liver disease (HP:0006706) | 1.93065877 |
| 66 | Seborrheic dermatitis (HP:0001051) | 1.91617588 |
| 67 | Patellar aplasia (HP:0006443) | 1.90999561 |
| 68 | Abnormality of the columella (HP:0009929) | 1.89884997 |
| 69 | Abnormality of B cell number (HP:0010975) | 1.89486102 |
| 70 | Leukocytosis (HP:0001974) | 1.89081486 |
| 71 | Abnormality of iron homeostasis (HP:0011031) | 1.88524036 |
| 72 | Hyperglycinemia (HP:0002154) | 1.87615848 |
| 73 | Abnormality of T cell physiology (HP:0011840) | 1.87572492 |
| 74 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87113592 |
| 75 | Stomach cancer (HP:0012126) | 1.83854977 |
| 76 | Basal cell carcinoma (HP:0002671) | 1.83210012 |
| 77 | Cholelithiasis (HP:0001081) | 1.82091249 |
| 78 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.81538961 |
| 79 | Cerebellar dysplasia (HP:0007033) | 1.81494835 |
| 80 | Inflammation of the large intestine (HP:0002037) | 1.80660025 |
| 81 | Anorexia (HP:0002039) | 1.79872268 |
| 82 | Prolonged partial thromboplastin time (HP:0003645) | 1.79805024 |
| 83 | Chronic hepatic failure (HP:0100626) | 1.79313565 |
| 84 | Abnormality of the renal cortex (HP:0011035) | 1.78963585 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 1.78609572 |
| 86 | Hypertensive crisis (HP:0100735) | 1.78561701 |
| 87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78170264 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 1.78170264 |
| 89 | Joint hemorrhage (HP:0005261) | 1.77184811 |
| 90 | Hyperventilation (HP:0002883) | 1.76789647 |
| 91 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.76561447 |
| 92 | Clumsiness (HP:0002312) | 1.76062620 |
| 93 | Renal cortical cysts (HP:0000803) | 1.75994148 |
| 94 | Vasculitis (HP:0002633) | 1.74470375 |
| 95 | Progressive inability to walk (HP:0002505) | 1.73766482 |
| 96 | Supernumerary ribs (HP:0005815) | 1.73421983 |
| 97 | Hypoplasia of the thymus (HP:0000778) | 1.72386867 |
| 98 | Polyneuropathy (HP:0001271) | 1.72335939 |
| 99 | Attenuation of retinal blood vessels (HP:0007843) | 1.72184646 |
| 100 | Hypoplasia of the pons (HP:0012110) | 1.71436239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.94779305 |
| 2 | MAP4K1 | 3.35080449 |
| 3 | MAP4K2 | 2.91229612 |
| 4 | TXK | 2.87520917 |
| 5 | GRK6 | 2.62824351 |
| 6 | SIK2 | 2.45169949 |
| 7 | MAPK15 | 2.40728658 |
| 8 | PINK1 | 2.36310519 |
| 9 | ZAK | 2.11193256 |
| 10 | BCKDK | 2.10119118 |
| 11 | TNK2 | 2.02371098 |
| 12 | MARK3 | 1.82484948 |
| 13 | FRK | 1.79923205 |
| 14 | FES | 1.73431613 |
| 15 | CDK12 | 1.69765004 |
| 16 | TLK1 | 1.68334097 |
| 17 | SYK | 1.66580412 |
| 18 | EPHA3 | 1.59444614 |
| 19 | BTK | 1.58623852 |
| 20 | ITK | 1.55382200 |
| 21 | MAP2K3 | 1.42079120 |
| 22 | TRIB3 | 1.37681662 |
| 23 | MAP3K10 | 1.35270327 |
| 24 | MAP2K6 | 1.34888616 |
| 25 | KDR | 1.25898986 |
| 26 | ZAP70 | 1.20785668 |
| 27 | MAP3K7 | 1.17491056 |
| 28 | NEK2 | 1.15831071 |
| 29 | CAMKK1 | 1.11749391 |
| 30 | IKBKB | 1.06738689 |
| 31 | PASK | 1.04565010 |
| 32 | VRK1 | 1.03267775 |
| 33 | MAPK13 | 1.02374143 |
| 34 | NME1 | 0.99686097 |
| 35 | HCK | 0.99636549 |
| 36 | EEF2K | 0.99025439 |
| 37 | RIPK4 | 0.97483225 |
| 38 | CAMKK2 | 0.97175856 |
| 39 | EPHB1 | 0.96762079 |
| 40 | LCK | 0.96752555 |
| 41 | MAPK12 | 0.95871639 |
| 42 | JAK3 | 0.95257130 |
| 43 | KIT | 0.94871796 |
| 44 | IKBKE | 0.94810478 |
| 45 | MAP2K7 | 0.94730286 |
| 46 | FGFR4 | 0.93579815 |
| 47 | CDK4 | 0.93064404 |
| 48 | MAP2K2 | 0.92894561 |
| 49 | ADRBK2 | 0.92705358 |
| 50 | NLK | 0.90422827 |
| 51 | INSRR | 0.89339756 |
| 52 | RPS6KA5 | 0.88993269 |
| 53 | MAP3K11 | 0.88323470 |
| 54 | PRKCQ | 0.88080893 |
| 55 | TYK2 | 0.87951860 |
| 56 | MAPK11 | 0.87553604 |
| 57 | DYRK1B | 0.85757613 |
| 58 | LYN | 0.83966224 |
| 59 | DAPK2 | 0.82301274 |
| 60 | CDK3 | 0.77919975 |
| 61 | PIM1 | 0.76684065 |
| 62 | CASK | 0.76450127 |
| 63 | BLK | 0.74815942 |
| 64 | FGFR2 | 0.73469121 |
| 65 | MAPKAPK3 | 0.71313258 |
| 66 | PRPF4B | 0.70865536 |
| 67 | MATK | 0.69608980 |
| 68 | TAOK1 | 0.69058997 |
| 69 | DYRK2 | 0.68969025 |
| 70 | ERN1 | 0.66718358 |
| 71 | HIPK2 | 0.65839706 |
| 72 | MAP2K4 | 0.62667739 |
| 73 | TEC | 0.62187658 |
| 74 | ATR | 0.61665823 |
| 75 | JAK2 | 0.59143977 |
| 76 | MAP3K4 | 0.58076440 |
| 77 | RPS6KA4 | 0.55143089 |
| 78 | RPS6KA6 | 0.53709572 |
| 79 | NTRK2 | 0.53644313 |
| 80 | CHUK | 0.53130009 |
| 81 | CSNK1A1L | 0.53112890 |
| 82 | TESK2 | 0.52133915 |
| 83 | CSNK1G3 | 0.52051084 |
| 84 | STK16 | 0.51346231 |
| 85 | BRD4 | 0.51315477 |
| 86 | CDK8 | 0.49496561 |
| 87 | PDK1 | 0.48182294 |
| 88 | MAPK7 | 0.47863020 |
| 89 | RPS6KC1 | 0.47168355 |
| 90 | RPS6KL1 | 0.47168355 |
| 91 | STK11 | 0.45320675 |
| 92 | DYRK3 | 0.42295179 |
| 93 | PRKAA1 | 0.41826214 |
| 94 | RPS6KA1 | 0.41777137 |
| 95 | JAK1 | 0.39744900 |
| 96 | TYRO3 | 0.39359844 |
| 97 | IRAK1 | 0.39090369 |
| 98 | OBSCN | 0.38525559 |
| 99 | CAMK4 | 0.37112476 |
| 100 | MARK2 | 0.37001530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.41265499 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.43502440 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.36739417 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.28033442 |
| 5 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.23748382 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16506190 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.06163049 |
| 8 | ABC transporters_Homo sapiens_hsa02010 | 2.03796717 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 1.98091238 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.75394282 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70535382 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.69106892 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62092875 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 1.58298490 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53273102 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50547166 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.50431812 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49247859 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.46984015 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38316391 |
| 21 | Phototransduction_Homo sapiens_hsa04744 | 1.36797064 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36526021 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.32910975 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.31916790 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.30974685 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.29552133 |
| 27 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.29533368 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25480934 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.23374900 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.21530822 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17271835 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14779734 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14355047 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11426471 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10660475 |
| 36 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.10367964 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10024868 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08914242 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 1.08173734 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06585173 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 1.06424127 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.04375313 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03830093 |
| 44 | Spliceosome_Homo sapiens_hsa03040 | 1.01944777 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00717413 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99979257 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99667847 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 0.99012139 |
| 49 | Nicotine addiction_Homo sapiens_hsa05033 | 0.97467861 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97127869 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94181391 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93044291 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86729169 |
| 54 | DNA replication_Homo sapiens_hsa03030 | 0.85539490 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83662016 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83131258 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82866146 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81760436 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79206127 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78401160 |
| 61 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78370173 |
| 62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77448841 |
| 63 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.75421493 |
| 64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.75170170 |
| 65 | RNA degradation_Homo sapiens_hsa03018 | 0.68781090 |
| 66 | Measles_Homo sapiens_hsa05162 | 0.68642891 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66899713 |
| 68 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.65749657 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64579864 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62795777 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62561918 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62542772 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.60031696 |
| 74 | Malaria_Homo sapiens_hsa05144 | 0.59274211 |
| 75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.58521559 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56833660 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56673288 |
| 78 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54497974 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54090868 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52889922 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52884629 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50891607 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50721451 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49065561 |
| 85 | GABAergic synapse_Homo sapiens_hsa04727 | 0.49024395 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.48849142 |
| 87 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48545833 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48314274 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47965231 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47880650 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45846897 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.42304652 |
| 93 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40741909 |
| 94 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40297196 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39424811 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39148056 |
| 97 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.38688655 |
| 98 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36420076 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36210823 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.35550980 |

